Sort
40,608 grants matching “prostate cancer”
Confirmation of SNPs Associated with Aggressive PCa in a GWA Study
$565,254Jianfeng Xu · Wake Forest University Health Sciences · R01 · FY2011 · CA
Glycoprotein Biomarkers for Early Detection of Aggressive Prostate Cancer
$565,219Hui Zhang · Johns Hopkins University · U01 · FY2016 · CA
Novel Quantitative, Comprehensive Proteomic Technology
$565,187Institute For Systems Biology · R33 · FY2001 · CA
MECHANISM OF PROSTATE CANCER PREVENTION BY DOWNREGULATION OF THE GH-IGF AXIS
$565,166University Of Illinois · · FY2009 · Department of the Army
The non-catalytic function of PARP2 in DNA repair and cancer therapy
$565,118Shan Zha · Columbia University Health Sciences · R01 · FY2024 · CA
Early Life Exposures and Subsequent Cancer Risk
$565,112Gretchen Gierach · Division Of Cancer Epidemiology And Genetics · ZIA · FY2024 · CA
Therapeutic implication of CD38 in CLL
$565,086Eduardo N Chini · Mayo Clinic Jacksonville · R01 · FY2023 · CA
PROMISS - Prostate Modeling to Identify Surveillance Strategies
$565,071Ruth D Etzioni · Fred Hutchinson Cancer Research Center · R01 · FY2017 · CA
Improved Management of GBM by Integrating Imaging and Tissue Analysis
$565,012Sarah J. Nelson · University Of California, San Francisco · P01 · FY2016 · CA
African American Families Fighting Parental Cancer Together
$564,992Adam Davey · University Of Delaware · R01 · FY2019 · CA
Infrastructure Support and Pilot Tissue Collection for the CARET Biorepository
$564,986Chu Chen · Fred Hutchinson Cancer Research Center · U01 · FY2018 · CA
TREATMENT DECISIONS AND PATIENT REPORTED OUTCOMES IN LOW RISK PROSTATE CANCER
$564,945Kathryn L Taylor · Georgetown University · R01 · FY2013 · CA
Prostate Cancer Risk Enhancers
$564,927Peggy J Farnham · University Of Southern California · R01 · FY2016 · CA
Genetic and Endocrine Pathways Linking Obesity with Prostate Cancer
$564,901Jay H Fowke · Vanderbilt University · R01 · FY2010 · CA
Molecular mechanisms underlying lineage plasticity in prostate cancer
$564,876Himisha Beltran · Dana-Farber Cancer Inst · R37 · FY2024 · CA
Synthesis Directed Toward Therapeutic Agents
$564,797Samuel J Danishefsky · Sloan-Kettering Inst Can Research · R01 · FY2013 · GM
Prostate Cancer Radio-Pathomics for Differentiating Clinically Significant Disease
$564,699Peter S Laviolette · Medical College Of Wisconsin · R01 · FY2024 · CA
DNA repair alterations in metastatic prostate cancer: functional and therapeutic implications
$564,655Alan Ashworth · University Of California, San Francisco · R01 · FY2018 · CA
QUALITY RESEARCH IN RADIATION ONCOLOGY: ACR PCS
$564,543Jesse F Wilson · American College Of Radiology · R01 · FY2009 · CA
Growth suppressive and oncogenic transcriptional programs controlled by the androgen receptor in prostate cancer
$564,543Christopher E Barbieri · Weill Medical Coll Of Cornell Univ · R01 · FY2025 · CA
Pharmacological Jak2 inhibition to overcome androgen receptor aberrations in prostate cancer
$564,525Marja T Nevalainen · Thomas Jefferson University · R01 · FY2024 · CA
11-Oxyandrogens and Aging: Health Implications
$564,488Adina F Turcu · University Of Michigan At Ann Arbor · R01 · FY2024 · AG
Vaginal Tactile Imager for Pelvic Floor Biomechanical Assessment
$564,443Vladimir Egorov · Artann Laboratories, Inc. · R44 · FY2011 · AG
Validation and Fine-Scale Mapping of Pancreatic Cancer Susceptibility Loci
$564,406Alison P Klein · Johns Hopkins University · R01 · FY2014 · CA
A COMBINATION APPROACH FOR TREATMENT OF CASTRATION-RESISTANT PROSTATE CANCER
$564,375The Administrators Of Tulane Educational Fund · · FY2015 · Department of Defense